Figure 1From: A comparative, randomized clinical trial of artemisinin/naphtoquine twice daily one day versus artemether/lumefantrine six doses regimen in children and adults with uncomplicated falciparum malaria in Côte d'IvoireA total of 123 participants over 125 complied freely with the study protocol up to the time of a new malaria episode or follow-up day 28 and had adequate data for the analysis of the endpoints.Back to article page